Cancer DNA in the blood can signal breast cancer’s return long before scans spot it, a new study shows.
A blood test that identifies tumor DNA circulating in the blood predicted 80 percent of breast cancer relapses after surgery and chemotherapy, researchers report August 26 in Science Translational Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.